The significance and potential anti-tumour effects of PAD2-specific inhibitors have been highlighted in multiple pre-clinical studies [89,90], though further research is required to understand the functions of PAD2-mediated citrullination events in the pathology of different types of cancer [87,88]. Here, PADI2 is linked to neoplasm.